Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesLaboratory/PathologyBaylor Scott & White Health Plan Vitamin Assays Co…
    Ask Trek AI about this page
    CurrentBaylor Scott & White Health PlanPolicy 242

    Vitamin Assays

    Customize your policy alerts

    Sign up for Baylor Scott & White Health Plan Policy 242 alerts

    Get alerted when Policy 242 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical coverage and limitations for laboratory vitamin assays and multi‑vitamin assay panels for Baylor Scott & White Health Plan members; applies across lines of business unless otherwise noted and references applicable Medicare LCDs/LCDs for Vitamin D testing.

    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyVitamin Assays
    Policy CodePolicy 242
    Change TypeNo material change
    Effective DateAug 1, 2026
    Last ReviewJul 23, 2026
    Next Review DateJul 23, 2027
    Key ActionOrder vitamin assays only with a qualifying diagnosis when required and avoid multi‑vitamin screening panels.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    multiplePanels considered screening
    annualVitamin D frequency limit
    CPT list

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CPT codes called out
    NoPrior authorization

    Coverage Position and Limitations

    inv-01: Coverage position and limitations

    Policy position and key coverage rules

    General coverage stance: BSWHP considers vitamin assay panels (more than one vitamin assay) a screening procedure and not medically necessary; assays for micronutrient testing that include multiple tests for vitamins, minerals, antioxidants and various metabolic functions are never necessary.

    [[chunk 2]]

    Vitamin D testing: Testing for Vitamin D deficiency (CPT 82308, 82652) is not medically necessary for general screening and requires a qualifying diagnosis as listed in the referenced non-Texas LCDs (L37535 and L34658). Once a member is found to be vitamin D deficient, further testing is medically necessary only to ensure adequate replacement; testing more often than annually is not considered medically necessary unless the member has a vitamin D deficiency.annual

    [[chunk 2],[chunk 1]]

    Code-specific limitations: Certain CPT codes have diagnosis-only, frequency-only, or both diagnosis and frequency limitations as listed: diagnosis-only (86352); frequency-only (82180, 84252, 84425, 84446, 84590, 84597); diagnosis and frequency limitations (82306, 82308, 82652, 82379, 82607, 82746, 83090, 84207, 85385, 83698).

    [[chunk 2]]

    Assays that measure multiple micronutrients—such as combined panels that include two or more vitamin tests or mixed tests for vitamins, minerals, antioxidants, and metabolic function—are considered screening procedures and are not medically necessary when ordered as routine population screening. BSWHP therefore does not cover multi‑vitamin or broad micronutrient panels intended for general screening purposes.

    Vitamin assay panels that include more than one vitamin assay are considered screening and are not medically necessary when ordered for general population screening. Claims for these panels may be denied; documentation should demonstrate a medically indicated reason when multiple assays are ordered together.

    Vitamin D testing (CPT 82308 and 82652) performed for general screening without a qualifying diagnosis listed in the referenced non‑Texas LCDs (L37535 and L34658) is not medically necessary. Once a member is confirmed vitamin D deficient, repeat testing is medically necessary only to document adequate replacement; testing more often than annually is not considered medically necessary unless the member has an ongoing deficiency that justifies more frequent monitoring.

    When Testing Is Covered

    inv-14: Evaluation of suspected vitamin deficiency with appropriate qualifying diagnosis (per LCD for Vitamin D testing).

    Covered when ALL of the following are met:

    Appropriate clinical indication: Clinical evaluation suggests a suspected vitamin deficiency (e.g., signs, symptoms, or laboratory findings consistent with deficiency).
    Vitamin-specific qualifying diagnosis: For Vitamin D testing (CPT 82308, 82652), a qualifying diagnosis listed in the referenced non-Texas LCDs (L37535 and L34658) must be documented; testing for Vitamin D without a qualifying diagnosis is not medically necessary for general screening.

    [[chunk 2],[chunk 1]]

    Follow-up testing: If Vitamin D deficiency has been established, repeat testing to document adequacy of replacement therapy is medically necessary; testing frequency should generally not exceed once per year unless clinically justified by ongoing deficiency.annual

    Codes and Frequency Rules

    Listed CPT CodesCPT
    82180Ascorbic acid (Vitamin C), blood
    82308Vitamin D; 25 hydroxy, includes fraction(s), if performed
    82379Carnitine (total and free), quantitative, each specimen
    82607Cyanocobalamin (Vitamin B-12)
    82652Vitamin D; 1,25 dihydroxy, includes fraction(s), if performed
    82746Folic acid; serum
    83090Homocysteine
    84207Pyridoxal phosphate (Vitamin B-6)
    84252Riboflavin (Vitamin B-2)
    84425Thiamine (Vitamin B-1)
    1–10 of 14
    1/2
    Vitamin D follow-up testing frequency
    Policy limitOnce a member is found to be vitamin D deficient, further testing is medically necessary only to ensure adequate replacement has been accomplished; testing more often than annually is not considered medically necessary unless the member has a vitamin D deficiency.
    Routine screeningVitamin D testing for general screening is not medically necessary and requires a qualifying diagnosis per referenced non‑Texas LCDs (L37535 and L34658).
    Applicable CPT codesThis frequency rule specifically applies to Vitamin D assays (CPT 82308 and 82652).
    Vitamin D assays (CPT 82308, 82652) frequency limit
    Annual limitVitamin D assays (CPT 82308, 82652): testing more often than annually is not considered medically necessary unless the member has a vitamin D deficiency.

    Ordering and Billing Guidance for Providers

    Prior Authorization

    No prior authorization required

    Prior authorization is not required for vitamin assays.

    Documentation Required

    Include qualifying diagnosis and indication on orders

    Order tests with appropriate supporting documentation: include the qualifying diagnosis where required by referenced LCDs and document the clinical indication and requested frequency.

    • Include the qualifying diagnosis listed in non‑Texas LCDs (L37535, L34658) for Vitamin D testing when applicable.
    • Document clinical indication and requested testing frequency, especially for codes with frequency limits.

    Services Not Covered

    Vitamin assay panels (multi‑vitamin/micronutrient panels) ordered for general screening are not covered. In addition, select CPT codes included in the policy may have specific diagnosis‑only, frequency‑only, or combined diagnosis and frequency restrictions; these code‑level limitations should be applied by automated claim edits and may render those individual tests not covered when the stated requirements are not met.

    Definitions

    Definition: Vitamin assay panels
    DefinitionMore than one vitamin assay ordered as a screening panel: considered a vitamin assay panel and treated as general screening; such panels are not medically necessary.
    ScopeIncludes assays for multiple vitamins, and assays that combine tests for vitamins, minerals, antioxidants, and metabolic functions (micronutrient panels).
    Coverage stanceAssays for micronutrient testing that include multiple tests are 'never necessary' when ordered as a panel and are not covered.

    Background

    Vitamin assays measure serum concentrations of individual vitamins (for example, vitamin D, vitamin B‑12, vitamin C, vitamins A and E, vitamin K, folate) to evaluate suspected deficiency. Routine population screening using multi‑vitamin or broad micronutrient panels is considered low‑value and is not supported by this policy. When clinical concern exists for a specific deficiency, individual vitamin tests may be appropriate with documentation of a qualifying diagnosis; vitamin D testing additionally requires adherence to LCD‑specified diagnoses and frequency guidance.

    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyVitamin Assays
    Policy CodePolicy 242
    Change TypeNo material change
    Effective DateAug 1, 2026
    Last ReviewJul 23, 2026
    Next Review DateJul 23, 2027
    Key ActionOrder vitamin assays only with a qualifying diagnosis when required and avoid multi‑vitamin screening panels.
    SourceLink
    On This Page
    Coverage Position and LimitationsWhen Testing Is CoveredCodes and Frequency RulesOrdering and Billing Guidance for ProvidersServices Not CoveredDefinitionsBackground

    [[chunk 2]]

    Screening restriction
    Testing for Vitamin D deficiency is not medically necessary for general screening and requires a qualifying diagnosis per non‑Texas LCDs L37535 and L34658.
    Support for editsThese frequency and diagnosis limitations may be enforced using automated claim edits as listed in the policy.
    Documentation Required

    Support medical necessity with diagnosis and frequency documentation

    Medical necessity must be supported by a qualifying diagnosis when required; document diagnosis and frequency limitations for specific CPT codes in the medical record and on the claim.

    • When Vitamin D testing is ordered, ensure the claim and record contain a qualifying diagnosis per the referenced non‑Texas LCDs (L37535, L34658).
    • For CPT codes with frequency limits, document reason for testing and prior test dates if repeating tests.
    Denial Risk

    Risk of denial for vitamin assay panels ordered as screening

    Vitamin assay panels (more than one vitamin assay) are considered screening and not medically necessary; claims for panels ordered for general screening may be denied.

    • Avoid ordering multi‑vitamin or micronutrient panels for general population screening without specific clinical indications.
    Denial Risk

    Risk of denial for Vitamin D screening without qualifying diagnosis

    Vitamin D testing without a qualifying diagnosis per the referenced LCDs is not medically necessary and may be denied.

    • For CPT codes 82308 and 82652, include a qualifying diagnosis from LCDs L37535 or L34658; testing for general screening is not covered.
    • Once deficiency is established, follow‑up testing is medically necessary only to confirm adequate replacement and generally no more often than annually unless deficiency persists.
    Note

    Ordering requirements: no prior authorization; include qualifying diagnoses

    No prior authorization is required; providers must order vitamin assays with supporting qualifying diagnoses where required by LCDs and document indication and frequency.

    • Prior authorization: Not required.
    • Include qualifying diagnosis on orders for Vitamin D testing per LCDs L37535 and L34658 when applicable.
    • Adhere to frequency limitations (e.g., no more often than annually for follow‑up vitamin D testing once deficient).